Literature DB >> 6418295

Blood pressure control during weight reduction in obese hypertensive men: separate effects of sodium and energy restriction.

B Fagerberg, O K Andersson, B Isaksson, P Björntorp.   

Abstract

The separate and combined effects of dietary energy and sodium restriction on regulation of blood pressure were investigated in 30 middle aged obese men with essential hypertension attending the outpatient department. In group 1 (n = 15) a basal period with no dietary restriction was followed by a period taking an energy reduced diet (5.1 MJ; 1230 kcal), the sodium intake being supplemented and hence unchanged (1:ErSn). In group 2 (n = 15) the basal period preceded a control period with no intervention, which was followed by taking a diet restricted in energy (5.1 MJ; 1220 kcal) and sodium (2:ErSr). During period 1:ErSn there were reductions in heart rate and urinary noradrenaline output but not in systolic or diastolic blood pressure. Body weight decreased by 4.9-11.7 kg and urinary sodium excretion did not change. In period 2:ErSr urinary sodium output was reduced by 81.4 (SEM 17.8) mmol(mEq)/24 h and there was a weight loss of 8.2 (SEM 0.7) kg. Systolic and diastolic blood pressures fell significantly, as did the heart rate and urinary noradrenaline excretion. These results show that in hypertensive obese men a moderate weight reducing diet decreases indices of sympathetic nervous system activity. Reduction of blood pressure to the normotensive range was observed only when there was a concomitant restriction of sodium intake.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6418295      PMCID: PMC1444105          DOI: 10.1136/bmj.288.6410.11

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  26 in total

1.  The estimation of catechol amines in urine.

Authors:  U von EULER; F LISHAJKO
Journal:  Acta Physiol Scand       Date:  1959-03-31

2.  Effects of long-term physical training on body fat, metabolism, and blood pressure in obesity.

Authors:  M Krotkiewski; K Mandroukas; L Sjöström; L Sullivan; H Wetterqvist; P Björntorp
Journal:  Metabolism       Date:  1979-06       Impact factor: 8.694

3.  Weight reduction in obesity by outpatient semistarvation.

Authors:  S M Genuth; J H Castro; V Vertes
Journal:  JAMA       Date:  1974-11-18       Impact factor: 56.272

Review 4.  Overweight and hypertension. A review.

Authors:  B N Chiang; L V Perlman; F H Epstein
Journal:  Circulation       Date:  1969-03       Impact factor: 29.690

5.  Dermal losses of nutrients and their significance for human metabolic balance studies.

Authors:  B Isaksson; B Lindholm; B Sjögren
Journal:  Acta Med Scand Suppl       Date:  1966

6.  Organization and efficacy of an out-patient hypertension clinic.

Authors:  O Anderson; G Berglund; L Hansson; R Sannerstedt; R Sivertsson; J Wikstrand; L Wilhelmsen
Journal:  Acta Med Scand       Date:  1978

7.  Weight reduction in a blood pressure clinic.

Authors:  L E Ramsay; M H Ramsay; J Hettiarachchi; D L Davies; J Winchester
Journal:  Br Med J       Date:  1978-07-22

8.  Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients.

Authors:  E Reisin; R Abel; M Modan; D S Silverberg; H E Eliahou; B Modan
Journal:  N Engl J Med       Date:  1978-01-05       Impact factor: 91.245

9.  The workinghman's diet. II. Effect of weight reduction in obese patients with hypertension, diabetes, hyperuricemia and hyperlipidemia.

Authors:  S Heyden
Journal:  Nutr Metab       Date:  1978       Impact factor: 4.169

10.  Orthogonal electrocardiogram, apex cardiogram, and atrial sound in normotensive and hypertensive 50-year-old men.

Authors:  J Wikstrand; G Berglund; L Wilhelmsen; I Wallentin
Journal:  Br Heart J       Date:  1976-08
View more
  16 in total

1.  By how much does dietary salt reduction lower blood pressure? III--Analysis of data from trials of salt reduction.

Authors:  M R Law; C D Frost; N J Wald
Journal:  BMJ       Date:  1991-04-06

Review 2.  Weight reduction for treatment of obesity-associated hypertension: nuances and challenges.

Authors:  Allyn L Mark
Journal:  Curr Hypertens Rep       Date:  2007-11       Impact factor: 5.369

3.  Lifestyle modifications to prevent and control hypertension. 5. Recommendations on dietary salt. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.

Authors:  J G Fodor; B Whitmore; F Leenen; P Larochelle
Journal:  CMAJ       Date:  1999-05-04       Impact factor: 8.262

4.  Long-term hemodynamic effects at rest and during exercise of newer antihypertensive agents and salt restriction in essential hypertension: review of epanolol, doxazosin, amlodipine, felodipine, diltiazem, lisinopril, dilevalol, carvedilol, and ketanserin.

Authors:  P Omvik; P Lund-Johansen
Journal:  Cardiovasc Drugs Ther       Date:  1993-04       Impact factor: 3.727

Review 5.  Physical activity in human hypertension. A mechanisms approach.

Authors:  W L Kenney; E J Zambraski
Journal:  Sports Med       Date:  1984 Nov-Dec       Impact factor: 11.136

Review 6.  Exercise and obesity.

Authors:  P J Pacy; J Webster; J S Garrow
Journal:  Sports Med       Date:  1986 Mar-Apr       Impact factor: 11.136

7.  Weight reduction and salt restriction in hypertension: effects on blood pressure and intracellular electrolytes.

Authors:  W Zidek; C Karoff; H Losse; H Vetter
Journal:  Klin Wochenschr       Date:  1986-11-17

8.  The longer-term effects of Roux-en-Y gastric bypass surgery on sodium excretion.

Authors:  Funda Celik; Mohamed Ahdi; Eelco W Meesters; Arnold van de Laar; Dees P M Brandjes; Victor E A Gerdes
Journal:  Obes Surg       Date:  2013-03       Impact factor: 4.129

9.  How useful is weight reduction in the management of hypertension?

Authors:  P R Croft; D Brigg; S Smith; C B Harrison; A Branthwaite; M F Collins
Journal:  J R Coll Gen Pract       Date:  1986-10

10.  Weight reduction lowers blood pressure independently of salt restriction.

Authors:  G De Simone; M Mancini; G Mainenti; S Turco; L A Ferrara
Journal:  J Endocrinol Invest       Date:  1992-05       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.